Imfinzi

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

AdvertisementHong Kong stock marketBusinessChina Business China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial 2-MIN READ2-MIN Listen…